GIANT Buy Signal: 5G/Billi...
According to this expert... if you buy just ONE stock in 2022, you should make it this one. Surprisingly... this stock trades for just $8. But it may not be $8 for much longer.
Click here to learn more...
Christopher Richard Anzalone, insider at Arrowhead Pharmaceuticals
Christopher Richard Anzalone Insider Alerts

Get notified the next time Christopher Richard Anzalone buys or sells Arrowhead Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Christopher Richard Anzalone Insider Information

Dr. Christopher Anzalone has been President, Chief Executive Officer and Director of the Company since December 1, 2007. In 2005, Dr. Anzalone formed and served as CEO of the Benet Group LLC, a private equity firm focused on creating and building new nano-biotechnology companies from university-generated science. Prior to his tenure at the Benet Group, he was a partner at the Washington, DC-based private equity firm Galway Partners, LLC, where he was responsible for sourcing, structuring, and building new business ventures. Prior to Galway, Dr. Anzalone was an NIH-supported post doctoral fellow in Reproductive Endocrinology at the Smithsonian Institution’s Conservation and Research Center. Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University.

What is Christopher Richard Anzalone's net worth?

The estimated net worth of Christopher Richard Anzalone is at least $132.41 million as of December 9th, 2020. Dr. Anzalone owns 2,521,561 shares of Arrowhead Pharmaceuticals stock worth more than $132,407,168 as of January 20th. This net worth evaluation does not reflect any other assets that Dr. Anzalone may own. Learn More.

What is Christopher Richard Anzalone's salary?

As the CEO of Arrowhead Pharmaceuticals, Inc., Dr. Anzalone earned a total compensation package of $14,294,517.00 in 2020. Dr. Anzalone earned a salary of $785,625.00, stock awards of $12,686,000.00, non-equity compensation of $820,000.00, and other compensation of $2,892.00.

How do I contact Christopher Richard Anzalone?

The corporate mailing address for Dr. Anzalone and other Arrowhead Pharmaceuticals executives is 177 E. Colorado Blvd Suite 700, Pasadena CA, 91105. Arrowhead Pharmaceuticals can also be reached via phone at (626) 304-3400 and via email at [email protected]

Has Christopher Richard Anzalone been buying or selling shares of Arrowhead Pharmaceuticals?

Christopher Richard Anzalone has not been actively trading shares of Arrowhead Pharmaceuticals during the last ninety days. Most recently, Christopher Richard Anzalone sold 60,000 shares of the business's stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $67.56, for a transaction totalling $4,053,600.00.

Who are Arrowhead Pharmaceuticals' active insiders?

Arrowhead Pharmaceuticals' insider roster includes Christopher Anzalone (CEO), Marianne De Backer (Director), Douglass Given (Director), James Hassard (Insider), Adeoye Olukotun (Director), and Javier San Martin (Insider).

Are insiders buying or selling shares of Arrowhead Pharmaceuticals?

In the last year, Arrowhead Pharmaceuticals insiders bought shares 1 times. They purchased a total of 655 shares worth more than $43,472.35. In the last year, insiders at the biotechnology company sold shares 13 times. They sold a total of 349,000 shares worth more than $25,168,421.25. The most recent insider tranaction occured on January, 5th when CFO Kenneth Allen Myszkowski sold 40,000 shares worth more than $2,468,000.00. Insiders at Arrowhead Pharmaceuticals own 3.5 % of the company.

Information on this page was last updated on 1/5/2022.

Christopher Richard Anzalone Insider Trading History at Arrowhead Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Sell60,000$67.56$4,053,600.00View SEC Filing Icon  
10/22/2021Sell50,000$65.63$3,281,500.00View SEC Filing Icon  
10/20/2021Sell15,000$66.23$993,450.00View SEC Filing Icon  
12/9/2020Sell38,676$69.06$2,670,964.562,521,561View SEC Filing Icon  
10/23/2020Sell100,000$58.21$5,821,000.00View SEC Filing Icon  
8/13/2020Sell50,000$41.35$2,067,500.002,655,237View SEC Filing Icon  
6/25/2020Sell100,000$38.81$3,881,000.002,605,260View SEC Filing Icon  
12/12/2019Sell100,000$67.50$6,750,000.002,048,684View SEC Filing Icon  
12/2/2019Sell37,967$69.15$2,625,418.052,116,160View SEC Filing Icon  
10/10/2019Sell56,325$31.83$1,792,824.752,178,228View SEC Filing Icon  
9/24/2019Sell66,645$28.20$1,879,389.002,146,153View SEC Filing Icon  
9/20/2019Sell4,250$29.00$123,250.002,146,153View SEC Filing Icon  
4/3/2019Sell50,000$19.30$965,000.00View SEC Filing Icon  
12/19/2018Sell90,000$13.92$1,252,800.00View SEC Filing Icon  
12/12/2018Sell90,000$14.07$1,266,300.00View SEC Filing Icon  
11/9/2018Sell81,500$14.39$1,172,785.001,727,755View SEC Filing Icon  
9/4/2018Sell164,834$14.45$2,381,851.301,868,789View SEC Filing Icon  
8/31/2018Sell100,000$14.45$1,445,000.001,868,789View SEC Filing Icon  
3/15/2018Sell300,000$7.43$2,229,000.002,194,789View SEC Filing Icon  
3/13/2018Sell100,000$7.43$743,000.002,194,789View SEC Filing Icon  
10/15/2014Buy16,000$6.32$101,120.00View SEC Filing Icon  
See Full Table

Christopher Richard Anzalone Buying and Selling Activity at Arrowhead Pharmaceuticals

This chart shows Christopher Richard Anzalone's buying and selling at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Company Overview

Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Read More

Today's Range

Now: $52.51
Low: $52.35
High: $55.59

50 Day Range

MA: $66.50
Low: $52.51
High: $74.04

2 Week Range

Now: $52.51
Low: $52.35
High: $93.66


872,889 shs

Average Volume

664,613 shs

Market Capitalization

$5.47 billion

P/E Ratio


Dividend Yield



Step by Step Guide To More Income!
Whether you are just starting to trade or believe you’re never too old to learn new tricks, "How To Master the Retirement Trade" is for you!

From options expert Dave Aquino, this e-book will guide you through the morning trade window bringing profits to newbies and seasoned pros alike.
Get yours now!